Workflow
BioLife Solutions(BLFS)
icon
Search documents
BioLife Solutions, Inc. (BLFS) Hit a 52 Week High, Can the Run Continue?
ZACKS· 2025-01-29 15:16
Have you been paying attention to shares of BioLife Solutions, Inc. (BLFS) ? Shares have been on the move with the stock up 9.8% over the past month. The stock hit a new 52-week high of $29.46 in the previous session. BioLife Solutions, Inc. has gained 9.8% since the start of the year compared to the -0.6% move for the Zacks Medical sector and the 20.9% return for the Zacks Medical - Products industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it ...
Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year?
ZACKS· 2025-01-24 15:41
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. BioLife Solutions, Inc. (BLFS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.BioLife Solutions, Inc. is one of 1010 companies in the Medical group. The Medical group currently sits at #2 within the Zacks Sector Rank. The Zacks ...
BioLife Solutions (BLFS) Is a Great Choice for 'Trend' Investors, Here's Why
ZACKS· 2025-01-22 14:50
Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it.Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, etc. -- ...
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations
Prnewswire· 2025-01-13 13:30
Fourth quarter Cell Processing revenue increased 7% sequentially to $20.3 million Unaudited revenue for FY2024 from Cell Processing of $73.5 million, exceeded the high end of previously raised guidance BOTHELL, Wash., Jan. 13, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced 2024 fourth quarter and full year preliminary unaudited revenue ...
BioLife Solutions Appoints Tony J. Hunt to its Board of Directors
Prnewswire· 2024-12-16 13:11
BOTHELL, Wash., Dec. 16, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the appointment of Tony J. Hunt, Executive Chairman of Repligen Corporation (Nasdaq: RGEN) and a recognized leader in bioprocessing innovation, to its board of directors effective January 2, 2025. His appointment increases board membership to six. "Tony is highly respected ...
BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary
Prnewswire· 2024-11-14 21:05
Completes the Company's strategic move away from capital equipment businessesBOTHELL, Wash., Nov. 14, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the sale of its final wholly owned freezer subsidiary, Arctic Solutions, Inc. ("Custom Biogenic Systems" or "CBS"), for $6.1 million in cash."We have now completed the divestiture of all our freeze ...
BioLife Solutions(BLFS) - 2024 Q3 - Earnings Call Transcript
2024-11-13 01:41
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Troy Wichterman - Chief Financial Officer Rod de Greef - Chairman and Chief Executive Officer Garrie Richardson - Chief Revenue Officer Conference Call Participants Matt Stanton - Jefferies Brendan Smith - TD Cowen Anna Snopkowski - KeyBanc Matt Hewitt - Craig-Hallum Capital Group LLC Thomas Flaten - Lake Street Capital Markets Jade Montgomery - H.C. Wainwright & Co., LLC Operator Good af ...
BioLife Solutions, Inc. (BLFS) Reports Q3 Loss, Tops Revenue Estimates
ZACKS· 2024-11-12 23:51
BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.67 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 77.78%. A quarter ago, it was expected that this company would post a loss of $0.14 per share when it actually produced a loss of $0.06, delivering a surprise of 57.14%.Over the last four quarters, the company has ...
BioLife Solutions(BLFS) - 2024 Q3 - Quarterly Report
2024-11-12 21:22
Table of Contents ____________________________________________________ Title of each class Trading symbol Name of exchange on which registered Common stock, par value $0.001 per share BLFS The NASDAQ Stock Market, LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ____________________________________________________ FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 o TRANSITION REPORT P ...
BioLife Solutions(BLFS) - 2024 Q3 - Quarterly Results
2024-11-12 21:12
3303 Monte Villa Parkway, Suite 310 | Bothell, WA 98021 USA | 866.424.6543 phone | BioLifeSolutions.com BioLife Solutions Reports Third Quarter 2024 Financial Results Cell Processing revenue grew 6% sequentially to $19.0 million; 43% increase compared to 2023 GAAP gross margin of 51% and non-GAAP adjusted gross margin of 54% GAAP net loss from continuing operations of $1.7 million and non-GAAP adjusted EBITDA of $6.1 million or 20% Increasing Cell Processing revenue guidance by $2 million to $72.0 to $73.0 ...